Nektar Therapeutics (NASDAQ:NKTR)

20.15
Delayed Data
As of Sep 20
 -0.07 / -0.35%
Today’s Change
16.56
Today|||52-Week Range
62.70
-38.70%
Year-to-Date

Today’s Trading

Previous close20.22
Today’s open20.25
Day’s range20.02 - 20.76
Volume4,841,687
Average volume (3 months)2,390,824
Market cap$3.5B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-175.35%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+287.81%
P/E ratioNM
Price/Sales4.96
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
MORMorphoSys AG-0.05-0.17%
IMMUImmunomedics Inc-0.46-2.70%
ONCESpark Therapeutics I...+0.35+0.34%
BPMCBlueprint Medicines ...+1.50+1.89%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$1.2B
Annual profit (last year)$681.3M
Net profit margin57.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts